Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: Study protocol for a phase II randomised controlled trial

Dena R. Howard, Talha Munir, Anna Hockaday, Andy C. Rawstron, Laura Collett, Jamie B. Oughton, David Allsup, Adrian Bloor, David Phillips, Peter Hillmen

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

1 results
- Title
- Start date(ascending)

Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial
Howard, D. R. (Contributor), Munir, T. (Contributor), Hockaday, A. (Contributor), Rawstron, A. C. (Contributor), Collett, L. (Contributor), Oughton, J. B. (Contributor), Allsup, D. (Contributor), Bloor, A. (Contributor), Phillips, D. (Contributor) & Hillmen, P. (Contributor), figshare , 20 Sept 2016
DOI: 10.6084/m9.figshare.c.3627080.v1, https://figshare.com/collections/Chemotherapy_plus_Ofatumumab_at_Standard_or_Mega_dose_in_relapsed_CLL_COSMIC_trial_study_protocol_for_a_phase_II_randomised_controlled_trial/3627080/1
Dataset